Compare MREO & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MREO | EDRY |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United Kingdom | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 60.3M |
| IPO Year | 2017 | 2018 |
| Metric | MREO | EDRY |
|---|---|---|
| Price | $0.33 | $20.90 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 23.7K |
| Earning Date | 05-12-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $6,000.20 | $28.30 |
| Revenue Next Year | $34.71 | $10.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $7.64 |
| 52 Week High | $2.94 | $23.98 |
| Indicator | MREO | EDRY |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 60.35 |
| Support Level | $0.32 | $12.28 |
| Resistance Level | $0.42 | $23.98 |
| Average True Range (ATR) | 0.02 | 1.24 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 29.29 | 87.04 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.